BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24335715)

  • 1. Phosphorus magnetic resonance spectroscopic imaging at 7 T in patients with prostate cancer.
    Lagemaat MW; Vos EK; Maas MC; Bitz AK; Orzada S; van Uden MJ; Kobus T; Heerschap A; Scheenen TW
    Invest Radiol; 2014 May; 49(5):363-72. PubMed ID: 24335715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (31) P MR spectroscopic imaging of the human prostate at 7 T: T1 relaxation times, Nuclear Overhauser Effect, and spectral characterization.
    Lagemaat MW; Maas MC; Vos EK; Bitz AK; Orzada S; Weiland E; van Uden MJ; Kobus T; Heerschap A; Scheenen TW
    Magn Reson Med; 2015 Mar; 73(3):909-20. PubMed ID: 24677408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional proton MR spectroscopy of human prostate at 3 T without endorectal coil: feasibility.
    Scheenen TW; Heijmink SW; Roell SA; Hulsbergen-Van de Kaa CA; Knipscheer BC; Witjes JA; Barentsz JO; Heerschap A
    Radiology; 2007 Nov; 245(2):507-16. PubMed ID: 17848681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 31P NMR of phospholipid metabolites in prostate cancer and benign prostatic hyperplasia.
    Komoroski RA; Holder JC; Pappas AA; Finkbeiner AE
    Magn Reson Med; 2011 Apr; 65(4):911-3. PubMed ID: 20967792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-grade prostatic intraepithelial neoplasia in patients with prostate cancer: MR and MR spectroscopic imaging features--initial experience.
    Hom JJ; Coakley FV; Simko JP; Lu Y; Qayyum A; Westphalen AC; Schmitt LD; Carroll PR; Kurhanewicz J
    Radiology; 2007 Feb; 242(2):483-9. PubMed ID: 17179396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardized threshold approach using three-dimensional proton magnetic resonance spectroscopic imaging in prostate cancer localization of the entire prostate.
    Fütterer JJ; Scheenen TW; Heijmink SW; Huisman HJ; Hulsbergen-Van de Kaa CA; Witjes JA; Heerschap A; Barentsz JO
    Invest Radiol; 2007 Feb; 42(2):116-22. PubMed ID: 17220729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution.
    Kurhanewicz J; Vigneron DB; Hricak H; Narayan P; Carroll P; Nelson SJ
    Radiology; 1996 Mar; 198(3):795-805. PubMed ID: 8628874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproducibility of 3D 1H MR spectroscopic imaging of the prostate at 1.5T.
    Lagemaat MW; Zechmann CM; Fütterer JJ; Weiland E; Lu J; Villeirs GM; Holshouser BA; van Hecke P; Lemort M; Schlemmer HP; Barentsz JO; Roell SO; Heerschap A; Scheenen TW
    J Magn Reson Imaging; 2012 Jan; 35(1):166-73. PubMed ID: 21960013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (31) P MR spectroscopic imaging combined with (1) H MR spectroscopic imaging in the human prostate using a double tuned endorectal coil at 7T.
    Luttje MP; Italiaander MG; Arteaga de Castro CS; van der Kemp WJ; Luijten PR; van Vulpen M; van der Heide UA; Klomp DW
    Magn Reson Med; 2014 Dec; 72(6):1516-21. PubMed ID: 24357271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Quality 3-Dimensional 1H Magnetic Resonance Spectroscopic Imaging of the Prostate Without Endorectal Receive Coil Using A Semi-LASER Sequence.
    Tayari N; Steinseifer IK; Selnæs KM; Bathen TF; Maas MC; Heerschap A
    Invest Radiol; 2017 Oct; 52(10):640-646. PubMed ID: 28632688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discriminating cancer from noncancer tissue in the prostate by 3-dimensional proton magnetic resonance spectroscopic imaging: a prospective multicenter validation study.
    Scheenen TW; Fütterer J; Weiland E; van Hecke P; Lemort M; Zechmann C; Schlemmer HP; Broome D; Villeirs G; Lu J; Barentsz J; Roell S; Heerschap A
    Invest Radiol; 2011 Jan; 46(1):25-33. PubMed ID: 21188832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral zone prostate cancer: accuracy of different interpretative approaches with MR and MR spectroscopic imaging.
    Westphalen AC; Coakley FV; Qayyum A; Swanson M; Simko JP; Lu Y; Zhao S; Carroll PR; Yeh BM; Kurhanewicz J
    Radiology; 2008 Jan; 246(1):177-84. PubMed ID: 18024434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 31P magnetic resonance spectroscopic imaging with polarisation transfer of phosphomono- and diesters at 3 T in the human brain: relation with age and spatial differences.
    Wijnen JP; Scheenen TW; Klomp DW; Heerschap A
    NMR Biomed; 2010 Oct; 23(8):968-76. PubMed ID: 20669234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential of magnetic resonance spectroscopic imaging in predicting absence of prostate cancer in men with serum prostate-specific antigen between 4 and 10 ng/ml: a follow-up study.
    Kumar R; Nayyar R; Kumar V; Gupta NP; Hemal AK; Jagannathan NR; Dattagupta S; Thulkar S
    Urology; 2008 Oct; 72(4):859-63. PubMed ID: 18329078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR spectroscopy of the human prostate using surface coil at 3 T: metabolite ratios, age-dependent effects, and diagnostic possibilities.
    Weis J; Jorulf H; Bergman A; Ortiz-Nieto F; Häggman M; Ahlström H
    J Magn Reson Imaging; 2011 Dec; 34(6):1277-84. PubMed ID: 21954046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy.
    Parivar F; Hricak H; Shinohara K; Kurhanewicz J; Vigneron DB; Nelson SJ; Carroll PR
    Urology; 1996 Oct; 48(4):594-9. PubMed ID: 8886066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localising prostate cancer: comparison of endorectal magnetic resonance (MR) imaging and 3D-MR spectroscopic imaging with transrectal ultrasound-guided biopsy.
    Goris Gbenou MC; Peltier A; Addla SK; Lemort M; Bollens R; Larsimont D; Roumeguère T; Schulman CC; van Velthoven R
    Urol Int; 2012; 88(1):12-7. PubMed ID: 22004874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated vs. manual pattern recognition of 3D (1)H MRSI data of patients with prostate cancer.
    Zechmann CM; Menze BH; Kelm BM; Zamecnik P; Ikinger U; Giesel FL; Thieke C; Delorme S; Hamprecht FA; Bachert P
    Acad Radiol; 2012 Jun; 19(6):675-84. PubMed ID: 22578226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyamines.
    Shukla-Dave A; Hricak H; Moskowitz C; Ishill N; Akin O; Kuroiwa K; Spector J; Kumar M; Reuter VE; Koutcher JA; Zakian KL
    Radiology; 2007 Nov; 245(2):499-506. PubMed ID: 17890357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative conformal optimization for transperineal prostate implantation using magnetic resonance spectroscopic imaging.
    Zelefsky MJ; Cohen G; Zakian KL; Dyke J; Koutcher JA; Hricak H; Schwartz L; Zaider M
    Cancer J; 2000; 6(4):249-55. PubMed ID: 11038145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.